Intelligence Platform
Patents
Browse 14,889 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6040167
Synthetic membrane vesicles containing functionally active fusion peptides as drug deliver
expired patentUS 6040340
Implantation rates after in vitro fertilization, treatment of infertility and early pregna
expired patentUS 6037370
Methods and compositions for stimulating neurite growth
expired patentUS 6037337
Use of the enantiomers of ifosfamide in antitumor therapy for reducing side effects
expired patentUS 6037125
Disruption of the mammalian RAD51 protein and disruption of proteins that associate with m
expired patentUS 6036976
Sustained release microspheres and preparation thereof
expired patentUS 6036955
Kits and methods for the specific coagulation of vasculature
expired patentUS 6033894
Kaposi's Syndrome Herpesvirus protease and assembly protein compositions and methods
expired patentUS 6034109
Method for protection of heart by limiting metabolic and ionic abnormalities developed dur
expired patentUS 6034065
Elucidation and synthesis of antineoplastic tetrapeptide phenethylamides of dolastatin 10
expired patentUS 6033864
Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof,
expired patentUS 6033845
Specific diagnostic for feline infectious peritonitis antibodies
expired patentUS 6033708
Method for producing sterile filterable liposome dispersion
expired patentUS 6033644
Biomodulators as universal imaging agents
expired patentUS 6031096
Acyclovir diester derivatives
expired patentUS 6030968
Positive AMPA receptor modulation to enhance brain neurotrophic factor expression
expired patentUS 6030952
Benzofuran-acrylic acid derivatives and their use as modulators of RXRs or RARs receptors
expired patentUS 6028207
Bone resorption inhibition/osteogenesis promotion compound
expired patentUS 6028198
Pharmaceutical composition for prevention and treatment of motion sickness syndrome
expired patentUS 6028171
Class I MHC modulation of surface receptor activity
expired patentUS 6028106
Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxid
expired patentUS 6028103
Triaryl methane compounds and analogues thereof useful for the treatment or prevention of
expired patentUS 6028068
Substituted 6H-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascul
expired patentUS 6028054
Method for increasing bioavailability of oral pharmaceutical compositions
expired